AMIKACIN and COUGH

Overview

COUGH is the #3 most commonly reported adverse reaction for AMIKACIN, manufactured by Insmed Incorporated. There are 1,620 FDA adverse event reports linking AMIKACIN to COUGH. This represents approximately 4.3% of all 37,285 adverse event reports for this drug.

Patients taking AMIKACIN who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is moderately reported among AMIKACIN users, representing a notable but not dominant share of adverse events.

Other Side Effects of AMIKACIN

In addition to cough, the following adverse reactions have been reported for AMIKACIN:

• OFF LABEL USE — 1,908 reports
• DRUG INEFFECTIVE — 1,673 reports
• DYSPNOEA — 1,556 reports
• HOSPITALISATION — 1,360 reports
• THERAPY INTERRUPTED — 1,348 reports
• DEATH — 1,103 reports
• DYSPHONIA — 977 reports
• PRODUCT DOSE OMISSION ISSUE — 730 reports
• NAUSEA — 721 reports
• FATIGUE — 702 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does AMIKACIN cause COUGH?

COUGH has been reported as an adverse event in 1,620 FDA reports for AMIKACIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with AMIKACIN?

COUGH accounts for approximately 4.3% of all adverse event reports for AMIKACIN, making it one of the most commonly reported side effect.

What should I do if I experience COUGH while taking AMIKACIN?

If you experience cough while taking AMIKACIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages